in

Durable responses to immunotherapy seen in rare angiosarcoma tumors

Durable responses to immunotherapy seen in rare angiosarcoma tumors

In a small study of 16 patients with the rare cancer angiosarcoma, tumors in four patients partially or completely responded to treatment with a combination of the immunotherapy drugs ipilimumab and nivolumab. Another two patients maintained stable disease on the drug combination. In some cases responses to treatment have been sustained for longer than one year, and at least one patient had their tumors disappear entirely.
Read More

What do you think?

Written by Alejandro Lupo

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Why Biden’s vaccination push now wields both carrot and stick

Why Biden’s vaccination push now wields both carrot and stick

Iran’s daily COVID deaths top 600 in new high

Iran’s daily COVID deaths top 600 in new high